Syra Health Corp. Class A Common Stock
SYRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $8 | $6 | $6 | $1 |
| % Growth | 44.7% | -1.8% | 298.4% | – |
| Cost of Goods Sold | $6 | $4 | $5 | $1 |
| Gross Profit | $2 | $1 | $1 | $0 |
| % Margin | 20.7% | 25.5% | 18.9% | 30.5% |
| R&D Expenses | $1 | $0 | $0 | $0 |
| G&A Expenses | $5 | $4 | $3 | $0 |
| SG&A Expenses | $1 | $4 | $3 | $0 |
| Sales & Mktg Exp. | -$3 | $0 | $0 | $0 |
| Other Operating Expenses | $3 | $0 | $0 | $0 |
| Operating Expenses | $5 | $4 | $3 | $0 |
| Operating Income | -$4 | -$3 | -$2 | -$0 |
| % Margin | -47.2% | -52.4% | -37.2% | -0.2% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$4 | -$3 | -$2 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$3 | -$2 | -$0 |
| % Margin | -47.1% | -53.3% | -37.7% | -0.2% |
| EPS | -0.52 | -0.6 | -0.36 | -0.001 |
| % Growth | 13.3% | -66.7% | -71,900% | – |
| EPS Diluted | -0.52 | -0.6 | -0.29 | -0.001 |
| Weighted Avg Shares Out | 7 | 5 | 6 | 7 |
| Weighted Avg Shares Out Dil | 7 | 5 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$3 | -$2 | -$0 |
| % Margin | -46.1% | -51.4% | -36.9% | -0.2% |